Search Results

Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapy.

• Authors : Forman R; Section of Medical Oncology, Internal Medicine Department, Yale School of Medicine, New Haven, CT, USA.; Long JB

Subjects: Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/drug therapy ; Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/economics ; Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/therapy

• Source: JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Sep 02; Vol. 8 (5).Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN:

Record details

sunitinib Pfizer files for EU approval for first-line renal cell carcinoma therapy.

• Source: R & D Focus Drug News. 2006.

Record details

hepatocellular carcinoma therapy, IC-Vec IC-Vec developing hepatocellular carcinoma therapeutics IC-Vec licensing agreement RNAi Co licensing agreement.

• Source: R & D Focus Drug News. 2004.

Record details

colon carcinoma therapy, Curis Curis discontinued, USA (cancer).

• Source: R & D Focus Drug News. 2004.

Record details

basal cell carcinoma therapy, Ontogeny Ontogeny identifies leadcandidate.

• Source: R & D Focus Drug News. 2000.

Record details

colon carcinoma therapy, Ontogeny Ontogeny licensing offer, Worldwide.

• Authors : Platika, Doros

• Source: R & D Focus Drug News. 2000.

Record details

Recent studies from Sungkyunkwan University add new data to oral squamous cell carcinoma therapy.

• Source: Cancer Weekly. 2009, pages. 469

Record details

Seattle Genetics, Inc. reports research in carcinoma therapy.

• Source: Blood Weekly. 2008, pages. 64

Record details

Cutaneous Papilloma and Squamous Cell Carcinoma Therapy Utilizing Nanosecond Pulsed Electric Fields (nsPEF).

• Authors : Yin, Dong; Yang, Wangrong G.; Weissberg, Jack

• Source: PLoS ONE. August 28, 2012, Vol. 7 Issue 8, e43891.

Record details

Renal Cell Carcinoma (Therapy) Phase II Cytokine Therapy Clinical Trial Commenced.

• Source: Cancer Weekly Plus. 1998.

Record details